Centenario Hospital Miguel Hidalgo

This study tests whether a daily synbiotic supplement (good bacteria plus prebiotic fiber) can lower inflammation in adults with chronic kidney disease who are not yet on dialysis. One hundred participants will take either the supplement or a placebo for 16 weeks. Researchers wil…

This study tests whether a 6-month program of a controlled diet, structured exercise, and a gut-health supplement (symbiotic) can reduce harmful toxins and inflammation in young people with early chronic kidney disease (CKD). Researchers will enroll 200 participants aged 12-25 wi…

This study tests whether a daily pill called dapagliflozin can reduce protein leakage in the urine of teenagers with mild-to-moderate chronic kidney disease. About 200 adolescents aged 14 to 18 will receive either the drug or a placebo for six months. The goal is to see if the dr…